Urinary IgG and α 2-macroglobulin are powerful predictors of outcome and responsiveness to steroids and cyclophosphamide in idiopathic focal segmental glomerulosclerosis with nephrotic syndrome

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Bazzi, Claudio ^a   Rizza, Virginia ^b   Casellato, Daniela ^b   Stivali, Gilda ^c   Rachele, Gregorio ^c   Napodano, Pietro ^b   Gallieni, Maurizio ^b   D'Amico, Giuseppe ^a  

^a D'Amico Foundation for Renal Diseases Research   (Italy)

^b SAN CARLO BORROMEO HOSPITAL   (Italy)

^c Baxter Renal   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE TITRATION; DRUG RESPONSE; FEMALE; FOCAL GLOMERULOSCLEROSIS; HIGH RISK POPULATION; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; MOLECULAR WEIGHT; MULTIVARIATE ANALYSIS; NEPHROTIC SYNDROME; OBSERVATIONAL STUDY; PREDICTIVE VALUE; REMISSION; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; URINARY EXCRETION; ADOLESCENT; AGED; CHRONIC KIDNEY FAILURE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; URINE; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-MACROGLOBULINS; CYCLOPHOSPHAMIDE; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOGLOBULIN G; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PROGNOSIS; STEROIDS; TREATMENT OUTCOME;

EID: 84884892635     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/941831     Document Type: Article

References (35)

1. Löwik M. M., Groenen P. J., Levtchenko E. N., Monnens L. A., van den Heuvel L. P., Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis-a review. European Journal of Pediatrics 2009 168 11 1291 1304 2-s2.0-70349621624 10.1007/s00431-009-1017-x
2. Gbadegesin R., Lavin P., Foreman J., Winn M., Pathogenesis and therapy of focal segmental glomerulosclerosis: an update. Pediatric Nephrology 2011 26 7 1001 1015 2-s2.0-79960853642 10.1007/s00467-010-1692-x
3. Rood I. M., Deegens J. K., Wetzels J. F., Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice. Nephrology Dialysis Transplantation 2012 27 3 882 890 10.1093/ndt/gfr771
4. Chun M. J., Korbet S. M., Schwartz M. M., Lewis E. J., Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. Journal of the American Society of Nephrology 2004 15 8 2169 2177 2-s2.0-3543082191 10.1097/01.ASN.0000135051. 62500.97 (Pubitemid 39031355)
5. Meyrier A., An update on the treatment options for focal segmental glomerulosclerosis. Expert Opinion on Pharmacotherapy 2009 10 4 615 628 2-s2.0-65649089840 10.1517/14656560902754029
6. Deegens J. K. J., Steenbergen E. J., Wetzels J. F. M., Review on diagnosis and treatment of focal segmental glomerulosclerosis. Netherlands Journal of Medicine 2008 66 1 3 12 2-s2.0-38849142542 (Pubitemid 351188283)
7. Shalhoub R. J., Pathogenesis of lipoid nephrosis: a disorder of T cell function. The Lancet 1974 2 7880 556 560 2-s2.0-0016266173
8. Meyrier A. Y., Treatment of focal segmental glomerulosclerosis with immunophillin modulation: when did we stop thinking about pathogenesis? Kidney International 2009 76 5 487 491 2-s2.0-68949206323 10.1038/ki.2009.204
9. Xing C. Y., Saleem M. A., Coward R. J., Ni L., Witherden I. R., Mathieson P. W., Direct effects of dexamethasone on human podocytes. Kidney International 2006 70 6 1038 1045 2-s2.0-33748430642 10.1038/sj.ki.5001655 (Pubitemid 44344073)
10. Meyrier A., Treatment of glomerular disease with cyclosporin A. Nephrology Dialysis Transplantation 1989 4 11 923 931 2-s2.0-0024785534 (Pubitemid 20050394)
11. Meyrier A., Treatment of idiopathic nephrosis by immunophillin modulation. Nephrology Dialysis Transplantation 2003 18 6 vi79 vi86 2-s2.0-0041382455 (Pubitemid 37098600)
12. Faul C., Donnelly M., Merscher-Gomez S., Chang Y. H., Franz S., Delfgaauw J., Chang J., Choi H. Y., Campbell K. N., Kim K., Reiser J., Mundel P., The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nature Medicine 2008 14 9 931 938 2-s2.0-51349162919 10.1038/nm.1857
13. Hardwicke J., White R. H. R., Williams A., Molecular size of IgG in patients with focal glomerulosclerosis. Clinical Nephrology 1976 6 1 290 294 2-s2.0-0017076558
14. Bazzi C., Petrini C., Rizza V., Napodano P., Paparella M., Arrigo G., Pisano L., D'Amico G., Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: a pilot study. The American Journal of Kidney Diseases 2003 41 2 328 335 2-s2.0-0037309691 10.1053/ajkd.2003.50040 (Pubitemid 36152450)
15. D'Amico G., Bazzi C., Pathophysiology of proteinuria. Kidney International 2003 63 3 809 825 2-s2.0-0037338437 10.1046/j.1523-1755.2003. 00840.x (Pubitemid 36315559)
16. D'Amico G., Ferrario F., Colasanti G., Ragni A., Bestetti B., IgA-mesangial nephropathy (Berger's disease) with rapid decline in renal function. Clinical Nephrology 1981 16 5 251 257 2-s2.0-0019409198 (Pubitemid 11027948)
17. D'Agati V. D., Fogo A. B., Bruijn J. A., Jennette J. C., Pathologic classification of focal segmental glomerulosclerosis: a working proposal. The American Journal of Kidney Diseases 2004 43 2 368 382 2-s2.0-0742323170 10.1053/j.ajkd.2003.10.024 (Pubitemid 38146337)
18. Levey A. S., Stevens L. A., Schmid C. H., Zhang Y., Castro A. F. III, Feldman H. I., Kusek J. W., Eggers P., van Lente F., Greene T., Coresh J., A new equation to estimate glomerular filtration rate. Annals of Internal Medicine 2009 150 9 604 612 2-s2.0-65649142017
19. Perkins R. M., Aboudara M. C., Uy A. L., Olson S. W., Cushner H. M., Yuan C. M., Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial. The American Journal of Kidney Diseases 2009 53 4 606 616 2-s2.0-62749098612 10.1053/j.ajkd.2008.11.026
20. Goicoechea M., de Vinuesa S. G., Quiroga B., Verdalles U., Barraca D., Yuste C., Panizo N., Verde E., Munoz M. A., Luno J., Effects of pentoxifylline on inflammatory parameters in chronic kidney disease patients: a randomized trial. Journal of Nephrology 2012 25 6 969 975 10.5301/jn.5000077
21. Badri S., Dashti-Khavidaki S., Ahmadi F., Mahdavy-Mazdeh M., Abbasi M. R., Khalili H., Effect of add-on pentoxifylline on proteinuria in membranous glomerulonephritis: a 6-month placebo-controlled trial. Clinical Drug Investigation 2013 33 3 215 222 10.1007/s40261-013-0057-1
22. McCormick B. B., Sydor A., Akbari A., Fergusson D., Doucette S., Knoll G., The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis. The American Journal of Kidney Diseases 2008 52 3 454 463 2-s2.0-47949128459 10.1053/j.ajkd.2008.01.025
23. McQuarrie E. P., Shakerdi L., Jardine A. G., Fox J. G., MacKinnon B., Fractional excretions of albumin and IgG are the best predictors of progression in primary glomerulonephritis. Nephrology Dialysis Transplantation 2011 26 5 1563 1569 2-s2.0-79955581606 10.1093/ndt/gfq605
24. Tofik R., Aziz R., Reda A., Rippe B., Bakoush O., The value of IgG-uria in predicting renal failure in idiopathic glomerular diseases. A long-term follow-up study. Scandinavian Journal of Clinical and Laboratory Investigation 2011 71 2 123 128 2-s2.0-79952370547 10.3109/00365513.2010.542828
25. Reichert L. J. M., Koene R. A. P., Wetzels J. F. M., Urinary IgG excretion as a prognostic factor in idiopathic membranous nephropathy. Clinical Nephrology 1997 48 2 79 84 2-s2.0-0030880326 (Pubitemid 27371035)
26. Bazzi C., Petrini C., Rizza V., Arrigo G., Beltrame A., Pisano L., D'Amico G., Urinary excretion of IgG and α 1-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy. The American Journal of Kidney Diseases 2001 38 2 240 248 2-s2.0-0034902841
27. Branten A. J. W., du Buf-Vereijken P. W., Klasen I. S., Bosch F. H., Feith G. W., Hollander D. A., Wetzels J. F., Urinary excretion of β 2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study. Journal of the American Society of Nephrology 2005 16 1 169 174 2-s2.0-21644475372 10.1681/ASN.2004040287 (Pubitemid 43073169)
28. Bazzi C., Rizza V., Raimondi S., Casellato D., Napodano P., D'Amico G., In crescentic IgA nephropathy, fractional excretion of IgG in combination with nephron loss is the best predictor of progression and responsiveness to immunosuppression. Clinical Journal of the American Society of Nephrology 2009 4 5 929 935 2-s2.0-68549140397 10.2215/CJN.05711108
29. Bazzi C., Rizza V., Paparella M., Casellato D., Napodano P., Olivieri G., D'Amico G., Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy. Journal of Nephrology 2009 22 3 387 396 2-s2.0-69449090806
30. Bazzi C., Rizza V., Casellato D., Stivali G., Rachele G., Napodano P., Olivieri G., Gallieni M., D'Amico G., Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy. Journal of Nephrology 2012 25 5 810 018 10.5301/jn.5000069
31. Bakoush O., Segelmark M., Torffvit O., Ohlsson S., Tencer J., Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis. Nephrology Dialysis Transplantation 2006 21 5 1263 1269 2-s2.0-33646180889 10.1093/ndt/gfk074
32. Tofik R., Torffvit O., Rippe B., Bakoush O., Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy. Diabetes Research and Clinical Practice 2012 95 1 139 144 2-s2.0-84355166542 10.1016/j.diabres.2011.10.008
33. Cammas B., Harambat J., Bertholet-Thomas A., Bouissou F., Morin D., Guigonis V., Bendeddouche S., Afroukh-Hacini N., Cochat P., Llanas B., Decramer S., Ranchin B., Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. Nephrology Dialysis Transplantation 2011 26 1 178 184 2-s2.0-78650650741 10.1093/ndt/gfq405
34. Irazabal M. V., Eirin A., Lieske J., Beck L. H., Sethi S., Borland T. M., Dillon J. J., Nachman P. H., Nasr S. H., Cornell L. D., Leung N., Cattran D. C., Fervenza F. C., Low- and high-molecular-weight proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study. Nephrology Dialysis Transplantation 2013 28 1 137 146 10.1093/ndt/gfs379
35. Jager K. J., Stel V. S., Wanner C., Zoccali C., Dekker F. W., The valuable contribution of observational studies to nephrology. Kidney International 2007 72 6 671 675 2-s2.0-34548515047 10.1038/sj.ki.5002397 (Pubitemid 47373787)